13:04:47 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



V:RX - BioSyent Inc. - http://www.biosyent.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RX - V  0.28.75·9.001.09.00+0.505.973.56541578.82  9.10  8.819.26  7.0316:39:43May 1615 min RT 2¢
TSX-V - V0.28.75·9.001.09.00+0.505.952.0464788.82  9.10  8.819.26  7.0316:39:4315 min
NEO ATS - U 8.99+0.495.81.81678.99  9.00  8.9915:57:4715 min
Omega - O 8.99+0.495.82.421159.00  9.09  8.8615:57:4715 min
Pure - P 8.500.113    15 min
Chi-X - X 9.08+0.586.80.1119.08  9.08  9.0812:08:4015 min
CX2 - H 8.99+0.495.87.062209.00  9.09  8.8615:57:4715 min
CXD - D 8.99+0.495.80.3278.99  8.99  8.9910:14:1815 min
TriAct - M 8.509.88626    Sep 11-2015 min

Recent Trades - Last 10 of 157
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:39:43V9.000.501,0001 Anonymous1 AnonymousK
15:59:32M9.000.509289 Raymond James14 Virtu ITGE
15:59:32V9.000.5010089 Raymond James7 TD SecK
15:59:32V9.000.5080089 Raymond James1 AnonymousK
15:58:17V9.000.503001 Anonymous7 TD SecK
15:58:17V9.000.509001 Anonymous1 AnonymousK
15:58:14V9.000.5020080 National Bank1 AnonymousK
15:58:14D9.000.502480 National Bank80 National BankE
15:57:47V8.990.4920089 Raymond James79 CIBCK
15:57:47M8.990.492689 Raymond James14 Virtu ITGE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-16 18:46C:RX8.50SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-16 18:40C:RX8.50SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-16 18:35C:RX8.50News ReleaseBioSyent earns $1.76-million in Q1
2024-05-16 18:03C:RX8.50News ReleaseBioSyent to pay 4.5-cent dividend June 15
2024-05-09 16:40C:RX8.59News ReleaseBioSyent to release Q1 results May 16
2024-04-25 10:13C:RX8.40SEDAR Annual ReportSEDAR Annual Report
2024-04-15 16:50C:RX8.64News ReleaseBioSyent extends licence for RepaGyn, Proktis-M
2024-03-27 18:38C:RX8.70News ReleaseBioSyent grants 66,020 RSUs
2024-03-13 17:47C:RX8.65SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-13 17:47C:RX8.65SEDAR MD & ASEDAR MD & A
2024-03-13 17:41C:RX8.65News ReleaseBioSyent earns $6.46-million in 2023
2024-03-06 16:37C:RX8.65News ReleaseBioSyent to release fiscal 2023 results March 13
2024-02-06 16:35C:RX8.75News ReleaseBioSyent increases quarterly dividend to 4.5 cents
2024-02-06 16:11C:RX8.60Dividend DeclaredBioSyent to pay 4.5-cent dividend
2023-12-13 16:12C:RX8.62Normal Course Issuer BidBioSyent normal course issuer bid
2023-12-13 11:47C:RX8.62News ReleaseBioSyent may buy back up to 650,000 shares under NCIB
2023-11-20 11:02C:RX8.30News ReleaseBioSyent begins shipping Gelclair to Canada
2023-11-16 10:23C:RX8.00News ReleaseBioSyent earns $2.35-million in Q3 2023
2023-11-16 08:13C:RX8.00SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-16 08:12C:RX8.00SEDAR Interim Financial StatementsSEDAR Interim Financial Statements